
News



Paranovus Entertainment Technology Limited Received Nasdaq Notification Letter Related to Late Filing of Form 6-K Reporting Interim Financial Information
Paranovus Entertainment Technology Ltd.



DKSH Malaysia Drives Sustainability with Innovative Green Initiatives
DKSH Malaysia Sdn. Bhd.



Clinical research results for Kelun-Biotech's TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
